Know Cancer

or
forgot password

Evaluation of Immune Parameters and Function in Multiple Myeloma Patients and Healthy Individuals' Blood and Marrow Samples


N/A
18 Years
N/A
Open (Enrolling)
Both
Multiple Myeloma

Thank you

Trial Information

Evaluation of Immune Parameters and Function in Multiple Myeloma Patients and Healthy Individuals' Blood and Marrow Samples


The blood and bone marrow samples will be used in the laboratory to perform focused studies
on multiple myeloma.


Inclusion Criteria:



- Participant population is multiple myeloma patients over the age of 18 who are
undergoing a scheduled bone marrow collection and/or blood drawing procedure as part
of their routine treatment or follow up, and healthy volunteers over the age of 18
who have agreed to have a bone marrow and/or blood harvest as part of a donation to a
transplant recipient.

Exclusion Criteria:

- Patients, who in the opinion of their physician, would be adversely affected by
removal of an extra15ml of blood and /or an extra 10ml of bone marrow.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Cancer cell response to molecular testing of killing cell parts.

Outcome Description:

This myeloma specific killing may help identify mechanisms, in vitro, of killing myeloma cells for the future use in clinical trials.

Outcome Time Frame:

2 Years

Safety Issue:

No

Principal Investigator

Kenneth Meehan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dartmouth-Hitchcock Medical Center

Authority:

United States: Institutional Review Board

Study ID:

D1029

NCT ID:

NCT01382615

Start Date:

August 2010

Completion Date:

June 2013

Related Keywords:

  • Multiple Myeloma
  • Multiple Myeloma
  • Multiple Myeloma
  • Neoplasms, Plasma Cell

Name

Location
Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire  03756